Gajjar, A.; Raju, A.K.; Gajjar, A.; Menon, M.; Shah, S.A.Y.; Dani, S.; Weinberg, A.
SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome. Biomedicines 2025, 13, 1924.
https://doi.org/10.3390/biomedicines13081924
AMA Style
Gajjar A, Raju AK, Gajjar A, Menon M, Shah SAY, Dani S, Weinberg A.
SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome. Biomedicines. 2025; 13(8):1924.
https://doi.org/10.3390/biomedicines13081924
Chicago/Turabian Style
Gajjar, Aryan, Arvind Kumar Raju, Amani Gajjar, Mythili Menon, Syed Asfand Yar Shah, Sourbha Dani, and Andrew Weinberg.
2025. "SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome" Biomedicines 13, no. 8: 1924.
https://doi.org/10.3390/biomedicines13081924
APA Style
Gajjar, A., Raju, A. K., Gajjar, A., Menon, M., Shah, S. A. Y., Dani, S., & Weinberg, A.
(2025). SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome. Biomedicines, 13(8), 1924.
https://doi.org/10.3390/biomedicines13081924
